The emerging role of bone markers in diagnosis and risk stratification of patients with coronary artery disease
Molecules that govern bone metabolism, such as osteoprotegerin (OPG) and osteopontin
(OPN), have been isolated from other tissues, including blood vessels. Atherosclerosis and …
(OPN), have been isolated from other tissues, including blood vessels. Atherosclerosis and …
Growth‐differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP‐SHOCK II …
G Fuernau, C Poenisch, I Eitel… - European journal of …, 2014 - Wiley Online Library
Aims This study investigates the role of osteoprotegerin (OPG) and growth‐differentiation
factor 15 (GDF‐15) as predictors of outcome in cardiogenic shock (CS) complicating acute …
factor 15 (GDF‐15) as predictors of outcome in cardiogenic shock (CS) complicating acute …
Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging
G Fuernau, S Zaehringer, I Eitel, S De Waha… - International journal of …, 2013 - Elsevier
Abstract Background/Objectives For osteoprotegerin (OPG), a cytokine of the tumor necrosis
factor superfamily, the prognostic impact in stable coronary artery disease and acute …
factor superfamily, the prognostic impact in stable coronary artery disease and acute …
The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome
ÖF Demir, NÖ Şensoy, E Akpınar, G Demir - Acta Diabetologica, 2024 - Springer
Aims The no-reflow phenomenon (NRP) is a common complication of saphenous vein graft
(SVG) interventions. The aim of this study was to investigate the effect of the stress …
(SVG) interventions. The aim of this study was to investigate the effect of the stress …
Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients …
OBJECTIVES: Osteoprotegerin (OPG) upregulates endothelial cell adhesion molecule
response to TNF-α by upregulating angiopoietin-2 (Ang-2). The aim of this study was to …
response to TNF-α by upregulating angiopoietin-2 (Ang-2). The aim of this study was to …
[PDF][PDF] Branch flow distribution approach and its application in the calculation of fractional flow reserve in stenotic coronary artery
H Zhang, J Xia, Y Yang, Q Yang, H Song, J Xie… - Math. Biosci …, 2021 - aimspress.com
Objective: To calculate fractional flow reserve (FFR) based on computed tomography
angiography (ie, FFRCT) by considering the branch flow distribution in the coronary arteries …
angiography (ie, FFRCT) by considering the branch flow distribution in the coronary arteries …
Osteoprotegerin levels change during STEMI and reflect cardiac function
S Lindberg, JS Jensen, S Hoffmann, AZ Iversen… - Canadian Journal of …, 2014 - Elsevier
Background High levels of circulating osteoprotegerin (OPG) predicts long-term outcome in
patients with ST-elevation myocardial infarction (STEMI), possibly because of increased …
patients with ST-elevation myocardial infarction (STEMI), possibly because of increased …
Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction
BB Løgstrup, DE Høfsten… - Coronary artery …, 2013 - journals.lww.com
Objective Osteoprotegerin (OPG) is a glycoprotein that inhibits nuclear factor-κB's regulatory
effects on inflammation, skeletal, and vascular systems, and is a potential biomarker of …
effects on inflammation, skeletal, and vascular systems, and is a potential biomarker of …
[HTML][HTML] Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction
A Çanga, ME Durakoğlugil, T Erdoğan, A Kırbaş… - Journal of …, 2012 - Elsevier
The aim of our study was to investigate whether osteoprotegerin (OPG) is related to in-
hospital major adverse cardiac events (MACE) and reperfusion parameters in patients with …
hospital major adverse cardiac events (MACE) and reperfusion parameters in patients with …